These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1421136)
1. Differential effects of deprenyl and MPTP on catecholamines and activity in BALB/c mice. Chia LG; Liu SP; Lee EH Neuroreport; 1992 Sep; 3(9):777-80. PubMed ID: 1421136 [TBL] [Abstract][Full Text] [Related]
2. Interactions among deprenyl, clorgyline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on catecholamines in mice. Lee EH; Yang YL; Chia LG; Kuo JS Neurosci Lett; 1994 Jan; 165(1-2):149-52. PubMed ID: 7912414 [TBL] [Abstract][Full Text] [Related]
3. Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB/c mice. Chang FW; Wang SD; Lu KT; Lee EH Brain Res Bull; 1993; 31(3-4):253-66. PubMed ID: 7683960 [TBL] [Abstract][Full Text] [Related]
5. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons. Rothblat DS; Schneider JS Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens. Wu WR; Zhu ZT; Zhu XZ Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868 [TBL] [Abstract][Full Text] [Related]
7. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl. Fuller RW; Hemrick-Luecke SK Life Sci; 1986 Nov; 39(18):1645-50. PubMed ID: 3095601 [TBL] [Abstract][Full Text] [Related]
8. L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse. Thiffault C; Lamarre-Théroux L; Quirion R; Poirier J Brain Res Mol Brain Res; 1997 Mar; 44(2):238-44. PubMed ID: 9073165 [TBL] [Abstract][Full Text] [Related]
9. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice. Wiener HL; Hashim A; Lajtha A; Sershen H J Neurosci Res; 1989 Jul; 23(3):326-9. PubMed ID: 2504936 [TBL] [Abstract][Full Text] [Related]
10. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151 [TBL] [Abstract][Full Text] [Related]
11. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice. Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972 [TBL] [Abstract][Full Text] [Related]
12. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP. Hemrick-Luecke SK; Robertson DW; Krushinski JH; Fuller RW Life Sci; 1992; 50(8):573-82. PubMed ID: 1736028 [TBL] [Abstract][Full Text] [Related]
13. Comparative studies of the neurotoxicity of MPTP in rats of different ages. Lee EH; Liu SP; Lu KT; Lin WR Chin J Physiol; 1992; 35(4):317-36. PubMed ID: 1364057 [TBL] [Abstract][Full Text] [Related]
14. MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN). Fredriksson A; Eriksson P; Archer T J Neural Transm (Vienna); 1997; 104(6-7):579-92. PubMed ID: 9444559 [TBL] [Abstract][Full Text] [Related]
15. A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity. Fuller RW; Hemrick-Luecke SK J Pharm Pharmacol; 1989 Jul; 41(7):492-3. PubMed ID: 2570859 [TBL] [Abstract][Full Text] [Related]
16. Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTP. Sziráki I; Kardos V; Patthy M; Pátfalusi M; Gaál J; Solti M; Kollár E; Singer J J Neural Transm Suppl; 1994; 41():207-19. PubMed ID: 7931228 [TBL] [Abstract][Full Text] [Related]
17. Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice. Gupta M; Wiener HL Neurochem Res; 1995 Apr; 20(4):385-9. PubMed ID: 7544444 [TBL] [Abstract][Full Text] [Related]
18. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium. Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity. Castagnoli K; Palmer S; Castagnoli N Neurobiology (Bp); 1999; 7(2):135-49. PubMed ID: 10591048 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. Fuller RW; Robertson DW; Hemrick-Luecke SK J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]